NewEdge Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.31M Buy
11,929
+986
+9% +$439K 0.03% 548
2025
Q1
$5.31M Sell
10,943
-1,708
-14% -$828K 0.03% 486
2024
Q4
$5.09M Buy
12,651
+1,294
+11% +$521K 0.03% 493
2024
Q3
$5.28M Sell
11,357
-2,275
-17% -$1.06M 0.03% 453
2024
Q2
$6.39M Buy
13,632
+709
+5% +$332K 0.05% 370
2024
Q1
$5.4M Buy
12,923
+2,619
+25% +$1.09M 0.05% 370
2023
Q4
$4.41M Buy
10,304
+650
+7% +$278K 0.04% 393
2023
Q3
$3.36M Buy
9,654
+1,128
+13% +$392K 0.04% 421
2023
Q2
$3M Buy
8,526
+3,034
+55% +$1.07M 0.03% 456
2023
Q1
$1.76M Sell
5,492
-262
-5% -$84.1K 0.02% 579
2022
Q4
$1.47M Sell
5,754
-275
-5% -$70.4K 0.04% 401
2022
Q3
$1.75M Buy
6,029
+1,354
+29% +$392K 0.03% 465
2022
Q2
$1.32M Buy
+4,675
New +$1.32M 0.02% 565
2022
Q1
Sell
-3,863
Closed -$848K 1640
2021
Q4
$848K Buy
3,863
+2,276
+143% +$500K 0.01% 819
2021
Q3
$288K Sell
1,587
-305
-16% -$55.4K 0.01% 915
2021
Q2
$381K Buy
1,892
+534
+39% +$108K 0.01% 815
2021
Q1
$292K Sell
1,358
-931
-41% -$200K 0.01% 822
2020
Q4
$541K Sell
2,289
-13,367
-85% -$3.16M 0.02% 600
2020
Q3
$4.26M Buy
15,656
+12,370
+376% +$3.37M 0.15% 145
2020
Q2
$954K Buy
3,286
+1,520
+86% +$441K 0.04% 370
2020
Q1
$420K Buy
1,766
+794
+82% +$189K 0.02% 503
2019
Q4
$212K Buy
+972
New +$212K 0.01% 750
2019
Q2
Sell
-1,280
Closed -$235K 705
2019
Q1
$235K Buy
1,280
+30
+2% +$5.51K 0.02% 592
2018
Q4
$207 Buy
+1,250
New +$207 0.01% 577
2017
Q3
Sell
-111
Closed -$14.3K 1108
2017
Q2
$14.3K Buy
+111
New +$14.3K ﹤0.01% 836